CVS Health Valuation

CVS -- USA Stock  

  Buyout Trend

CVS Health shows prevailing Real Value of $79.66 per share. The current price of the firm is $73.0. At this time the firm appears to be undervalued. This module approximates value of CVS Health from analyzing the firm fundamentals such as Return On Equity of 0.09  and Profit Margin of 0.0191  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
Undervalued
November 14, 2019
73.00
Market Value
79.66
Real Value
83.92
Upside
CVS Health is very steady asset. Calculation of real value of CVS Health is based on 3 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

CVS Health Market Cap

CVS Health Corporation is rated fourth in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 383.34 Billion. CVS Health totals roughly 90.01 Billion in market capitalization claiming about 23% of equities under Health Care Plans industry.
Capitalization  Valuation  Revenue  Total debt  Workforce
Horizon     30 Days    Login   to change
CVS Health Corporation is rated below average in price to earning category among related companies. It is rated below average in beta category among related companies totaling about  0.04  of Beta per Price to Earning. The ratio of Price to Earning to Beta for CVS Health Corporation is roughly  23.13 

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio0.52
Earnings Quarterly Growth10.10%
Revenue Growth36.60%
Payout Ratio59.70%
Enterprise Value To Ebitda11.22
Earnings Growth-14.00%
Enterprise Value To Revenue0.73
Check also Trending Equities. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Search macroaxis.com